News Conference News EAPCI 2026 EAPCI Summit 2026: What to Expect in Munich Caitlin E. Cox February 11, 2026
News Conference News ESC Heart Failure 2025 AI-ECG Helps Find Subclinical Heart Failure in Kenya Todd Neale May 19, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025
News Conference News AHA 2024 One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024 Shelley Wood November 14, 2024
News Conference News ISET 2024 AI Tools Can Flourish in CV Medicine, but Clinical Acumen Remains Key Caitlin E. Cox January 23, 2024
News Conference News AHA 2023 Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation L.A. McKeown November 17, 2023
News Conference News SCCT 2023 AI Predicted to Play Major Role in Cardiac CT and CV Care in the Coming Decade Todd Neale August 03, 2023
News Conference News SCCT 2023 Population Screening for Coronary Plaque: Is the Evidence Enough? Todd Neale July 31, 2023
News Conference News ACC 2023 ‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk Caitlin E. Cox March 10, 2023
News Conference News TCT 2022 Pascal TEER Device Performs Well in Patients With Complex Anatomy Yael L. Maxwell September 26, 2022
News Conference News TCT 2022 As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant Michael O'Riordan September 18, 2022
News Conference News TCT 2022 HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza Todd Neale September 16, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News EAS 2022 FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses Michael O'Riordan May 26, 2022
News Conference News EAS 2022 Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering Michael O'Riordan May 24, 2022
News Conference News EuroPCR 2022 TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days Yael L. Maxwell May 19, 2022
News Conference News EuroPCR 2022 Registry Data Hint at MACE Benefit With Renal Denervation Michael O'Riordan May 17, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
News Conference News TCT 2019 Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety L.A. McKeown September 25, 2019